About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 435 record(s)
Req # A-2023-000289
Adverse Drug Reaction (ADR). Report number: 001033517.Organization: Health Canada
June 2023
Req # A-2023-000311
Adverse Drug Reactions (ADRs). Report numbers: 001018620, 001018334, 001011335, 001015044, 001014046, 001010260, 001017628.Organization: Health Canada
June 2023
Req # A-2023-000316
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-101815-520, Exceptions for the Information Technology Community.Organization: Health Canada
June 2023
Req # A-2023-000329
Adverse Drug Reaction (ADR) for PMS-NITROFURANTOIN. Report number: 001025974.Organization: Health Canada
June 2023
Req # A-2023-000368
Adverse Drug Reaction (ADR) for RIVA-ARIPIPRAZOLE. Report number: 001038374.Organization: Health Canada
June 2023
Req # A-2022-00053
(1) Copies of all contracts, from Jan. 1 2015 to Feb. 12, 2023, for the provision of Indigenous Knowledge/Aboriginal Knowledge services (including the contract with Firelight Group (procurement ID: 3000603846). (2) Copies of any final reports that arise from any of these contracts, and any decision documents that reference any of these contracts (including any final report from Firelight Group (procurement ID: 3000603846)). (3) Any records providing guidance on Government of Canada's mandatory minimum target for all departments to require of 5% of the total value of contracts to go to Indigenous businesses.Organization: Impact Assessment Agency of Canada
June 2023
Req # A-2022-00057
Copies of the 'Detailed Project Description' (including all draft copies) pertaining to what is now known as the "Cedar LNG" project. The requester is aware of certain documents that are available publicly via the Canadian Impact Assessment Registry (the "Registry") and requests only those documents which have not already been made available via the Registry. In so far as they are available, digital copies of documents are preferred. The requester also requests only copies of French documents where English documents are not provided.Organization: Impact Assessment Agency of Canada
June 2023
Req # A-2022-000104
Obtain copies of all documents concerning the Company, including its capacity as tenant of the building located at: Company: Cozey Inc. NEQ: 1174955287. Building address: 5770 Ferrier St., Mont-Royal, QC H4P 1M7, Canada. Cadastre: 1 679 001. Owners: Summit Corporation Inc.Organization: Health Canada
June 2022
Req # A-2022-000242
All information pertaining to the Company or confirmation that the Company is in good standing with your organization. Company: Maturin 9374-1502 QUÉBEC INC. (NEQ: 1173467094) (BN: 714460714). Address: 201-125 Ste-Foy Blvd., Longueuil, QC J4J 1W7.Organization: Health Canada
June 2022
Req # A-2017-000370
All reviewers’ reports regarding the cleared New Drug Submission (NDS) for TECENTRIQ (atezolizumab), manufactured by Roche.Organization: Health Canada
June 2022